Latest Articles

Publication Date
All News Scientific
Gefapixant Shows Why Uncertain Results Still Matter - streamlinefeed.co.ke

Gefapixant Shows Why Uncertain Results Still Matter streamlinefeed.co.ke

Published: Aug. 21, 2026, 9 a.m.
Read Full Article
Randomized, controlled, proof-of-concept trial of gefapixant for endometriosis-related pain.

To evaluate the P2X3 receptor antagonist, gefapixant, for treating moderate-to-severe endometriosis-related pain.

Published: Sept. 9, 2024, midnight
Read Full Article
Gefapixant P2X3 receptor Pain Randomized clinical trial
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!